Search Thermo Fisher Scientific
Discover available B·R·A·H·M·S Biomarker Assays
B·R·A·H·M·S Biomarkers offer outstanding long-term lot-to-lot stability, delivering highly accurate and precise results for preeclampsia management.
B·R·A·H·M·S PlGF plus KRYPTOR
Intended uses
| Progression to preeclampsia with severe features within 2 weeks of presentation |
| Week 24+0 to 34+6 |
 |
Product specifications
| Sample volume | 70 µL |
| Sample type | Serum, EDTA plasma |
| Incubation time | 29 min |
| Linear direct measuring range | 7.6 to 4,000 pg/mL |
| Limit of detection | 4.9 pg/mL |
| Limit of quantification | 7.6 pg/mL |
| Kit stability on board | 29 days |
| Calibrator | 1 point |
| Calibration stability | 15 days |
B·R·A·H·M·S sFlt-1 KRYPTOR
Intended uses
| Progression to preeclampsia with severe features within 2 weeks of presentation |
| Week 24+0 to 34+6 |
|
Product specifications
| Sample volume | 8 µL |
| Sample type | Serum, EDTA plasma |
| Incubation time | 9 min |
| Linear direct measuring range | 315 to 90,000 pg/mL |
| Limit of detection | 28.5 pg/mL |
| Limit of quantification | 29.4 pg/mL |
| Kit stability on board | 29 days |
| Calibrator | 2 point |
| Calibration stability | 15 days |
Thermo Fisher Scientific products are distributed globally and their uses, applications, indications, claims and availability of products in each country depend on local regulatory marketing authorization status, please consult the Instructions For Use (IFU) available in your country.
© 2024 Thermo Fisher Scientific Inc. All rights reserved. All trademarks are the property of Thermo Fisher Scientific and its subsidiaries unless otherwise specified. B·R·A·H·M·S is a registered trademark of B·R·A·H·M·S GmbH.
KRYPTOR and TRACE are trademarks of Cisbio Bioassays, licensed for use by B·R·A·H·M·S GmbH, a part of Thermo Fisher Scientific. Nobel Prize is a registered trademark of the Nobel Foundation.